Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Suzhou Zelgen Biopharmaceuticals Co Ltd

688266
Current price
65.22 CNY -2.76 CNY (-4.06%)
Last closed 67.99 CNY
ISIN CNE100003RP1
Sector Healthcare
Industry Biotechnology
Exchange Shanghai Stock Exchange
Capitalization 17 582 907 281 CNY
Yield for 12 month +36.87 %
1Y
3Y
5Y
10Y
15Y
688266
21.11.2021 - 28.11.2021

Suzhou Zelgen Biopharmaceuticals Co.,Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers donafenib tablets; recombinant human thrombin for topincal use; jacktinib tablets; and recombinant human thyroid-stimulating hormone for injection; obeticholic acid magnesium tablets; ZG19018 tablets; ZG005 powder for injection; and alkotinib capsules for the treatment of liver cancer, non-small cell lung cancer, small cell lung cancer, colorectal cancer, thyroid cancer, and neuroendocrine cancer, as well as multiple therapeutic areas, such as bleeding, hepatobiliary diseases, and autoimmune diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China. Address: No. 209, Chenfeng Road, Kunshan, China, 215300

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

419.49 CNY

P/E ratio

Dividend Yield

Current Year

+387 569 475 CNY

Last Year

+303 189 582 CNY

Current Quarter

+132 839 870 CNY

Last Quarter

+108 561 127 CNY

Current Year

+358 271 905 CNY

Last Year

+276 952 011 CNY

Current Quarter

+122 462 831 CNY

Last Quarter

+101 390 993 CNY

Key Figures 688266

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -268 650 012 CNY
Operating Margin TTM -25.92 %
PE Ratio
Return On Assets TTM -6.5 %
PEG Ratio
Return On Equity TTM -12.48 %
Wall Street Target Price 419.49 CNY
Revenue TTM 489 880 338 CNY
Book Value 4.94 CNY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 130.7 %
Dividend Yield
Gross Profit TTM 305 808 361 CNY
Earnings per share -0.66 CNY
Diluted Eps TTM -0.66 CNY
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -35.7 %

Dividend Analytics 688266

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 688266

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 688266

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 32.203
Price Sales TTM 35.8923
Enterprise Value EBITDA -20.7662
Price Book MRQ 13.0507

Financials 688266

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 688266

For 52 weeks

33.3 CNY 80.22 CNY
50 Day MA 61.75 CNY
Shares Short Prior Month
200 Day MA 54.01 CNY
Short Ratio
Shares Short
Short Percent